Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;12(9):2545-2556.
doi: 10.1007/s13300-021-01130-x. Epub 2021 Aug 11.

Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes

Affiliations

Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes

Eddy Jean-Baptiste et al. Diabetes Ther. 2021 Sep.

Abstract

Introduction: Controlling insulin-treated diabetes is challenging in low-resource settings where only Neutral Protamine Hagedorn (NPH), regular (R) and premixed insulin formulations are available, self-monitoring of blood glucose (SMBG) supplies are scarce and food insecurity is common. We examined the impact of a treatment protocol that includes sliding scale-based 70/30 insulin adjustments in Haiti.

Methods: Thirty young patients aged 11-28 years with diabetes treated with premixed 70/30 insulin twice daily were included in the study. The participants performed one or two daily self-monitoring of blood glucose (SMBG) tests and attended our diabetes clinic monthly. They were randomized to two treatment groups, with one group remaining on the 70/30 insulin formulation (group 70 [G70]) and the other group switching to self-mixed NPH + R (group NR [GNR]). Sliding scales for insulin correction doses and meal insulin doses were designed based on the total daily insulin dose (TDD), carbohydrate ratio and insulin sensitivity factor. SMBG tests and insulin were administered before the morning and evening meals. The frequency of visits to the diabetes clinic was increased to biweekly during a 14-week follow-up.

Results: Fifteen patients of each group were included in the analysis. Baseline characteristics, increase in total daily dose and number of missed SMBG tests and skipped meals at 14 weeks did not differ between the two groups. Hemoglobin A1c (HbA1c) decreased from 9.5% (interquartile range [IQR] 8.8, 10.5) (80.3 mmol/mol) to 8.0% (IQR 7.1%, 9.0%) (63.9 mmol/mol) in G70 (p = 0.01), and from 10.6% (IQR 8.1,% 13.1)% (92.4 mmol/mol) to 9.0% (IQR 7.6%, 9.6%) (74.9 mmol/mol) in GNR (p = 0.10), with no significant between-group difference in reductions (p = 0.12). No serious acute complications were reported. Stopping the use of sliding scales and resuming monthly visits increased HbA1c to values not significantly different from baseline in both groups after 15 weeks.

Conclusion: The use of sliding scales adjusted for missed SMBG tests and skipped meals, and frequent clinic visits that focus on patient self-management education significantly improved glycemic control in the patients with youth-onset diabetes in our study treated with premixed 70/30 human insulin in a low-resource setting.

Keywords: Insulin-treated diabetes; Low-resource setting; Missed self-monitoring of blood glucose tests; Premixed insulin; Self-management education; Self-mixed insulin; Skipped meals; Sliding scales; Youth-onset diabetes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Change in glycated hemoglobin (HbA1c) during the study period. In both treatment groups, HbA1c decreased significantly after 14 weeks, and re-increased to values not significantly different from baseline after 29 weeks

References

    1. The Diabetes Control and Complications Trial Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968–983. doi: 10.2337/diab.44.8.968. - DOI - PubMed
    1. DiMeglio LA, Acerini CL, Codner E, et al. ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19(Suppl 27):105–114. doi: 10.1111/pedi.12737. - DOI - PubMed
    1. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019;21:66–72. doi: 10.1089/dia.2018.0384. - DOI - PMC - PubMed
    1. Willi SM, Miller KM, DiMeglio LA, et al. Racial-ethnic disparities in management and outcome among children with type 1 diabetes. Pediatrics. 2015;135:424–434. doi: 10.1542/peds.2014-1774. - DOI - PMC - PubMed
    1. Borschuk AP, Everhart RS. Health disparities among youth with type 1 diabetes: a systematic review of the current literature. Fam Syst Health. 2015;33:297–313. doi: 10.1037/fsh0000134. - DOI - PubMed

LinkOut - more resources